Privium Fund Management B.V. Apellis Pharmaceuticals, Inc. Transaction History

Privium Fund Management B.V.

  • $401 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
SELL
$44.76 - $69.66 $2.01 Million - $3.13 Million
-45,000 Reduced 32.7%
92,616 $6.06 Million
Q1 2022

May 10, 2022
BUY
$35.46 - $54.12 $354,600 - $541,200
10,000 Added 7.84%
137,616 $6.99 Million
Q4 2021

Feb 09, 2022
BUY
$30.74 - $49.16 $3.92 Million - $6.27 Million
127,616 New
127,616 $6.12 Million

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email